Abstract Purpose of Review Recent treatment advances in both acute myeloid leukemia and
acute lymphoblastic leukemia have drastically improved outcomes for these diseases, but …

Opinion statement Improvements in systemic therapy in the treatment of acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and …

The central nervous system (CNS) is the most important site of extramedullary disease in
adults with acute lymphoblastic leukemia (ALL). Although CNS disease is identified only in a …

In adult patients with acute lymphoblastic leukemia (ALL), Central Nervous System (CNS)
involvement is associated with a very poor prognosis. The diagnostic assessment of this …

The risk of development of CNS leukemia was investigated in 153 adults with acute
lymphocytic leukemia (ALL) who received systemic combination chemotherapy without CNS …

Central nervous system (CNS) recurrence continues to be a significant complication in the
treatment of adult patients with acute lymphoblastic leukemia (ALL). Preventing CNS …

The central nervous system (CNS) is an important site of involvement by acute lymphoblastic
leukemia (ALL) in adults. The prevalence is sufficiently high that prophylactic treatment is …

Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …

Central nervous system (CNS) involvement is identified at the time of diagnosis in less than
5% of children with acute lymphocytic leukemia (ALL). 9 Before the institution of adequate …

To determine the incidence of central nervous system leukemia (CNSL) in adults with acute
leukemia (AL) we studied 299 patients admitted from 1966 to 1971, and reviewed 170 …